Resent in plain text as did not appear before: These is only just over a week to secure your place on these two 2-day courses; they are designed to be taken together if you are new to NLME or you can take just the level you are interested in; if you sign up for both, or more than one from your organization you will have a discount on the listed prices; as will those from academic institutions.
Discount 30% off for 2 or more bookings. 50% off for students 18-19 November 2014 New or beginner users will learn how to perform population PK/PD using Phoenix NLME. This will be a two-day hands-on workshop with introductory theory of Population PK/PD. Topics include: Basic concepts of the Phoenix Platform, specialized workflows for population PK/PD modeling and simulation, analyzing rich vs sparse datasets, modeling sources of variability model validation and much more. 20-21 November 2014 Intermediate Population Modeling Methodology using Phoenix NLME: Pharmacometrics in Practice Serge Guzy provides this two day course that will focus on Pharmacokinetic and Pharmacodynamic (continuous and categorical) modeling and simulation using the intuitive interface of Phoenix NLME. The course combines presentations of theory of Population PK/PD with hands-on practice for each topic. Topics include: Theory, Hands-on, Analysis, Built-in Models, Graphical Models Clinical Trial Simulation: Case studies, Optimization of dosage, Allometric Scaling Categorical Response Analysis, Multi-level data Analysis, Theory, Test Cases, Modeling strategies, Time to event analysis. Best regards, Simon. ___________________________________ [email protected] Senior Scientific Consultant Pharsight- A Certara™ Company Mobile : +44 7980 832 666 ___________________________________ https://www.certara.com/training Intro (Tue-Wed) & Intermediate (Thur-Fri) NLME with Phoenix 18-21 Nov 2014, Paris, France Intro to Phoenix WinNonlin (Mon-Tue) & Intro to NLME (Wed-Thur) NLME with Phoenix 1-4Dec 2014,Barcelona, Spain NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
